tiprankstipranks
Trending News
More News >
Comprehensive Healthcare Systems Inc (TSE:CHS)
:CHS
Canadian Market

Comprehensive Healthcare Systems Inc (CHS) AI Stock Analysis

Compare
3 Followers

Top Page

TS

Comprehensive Healthcare Systems Inc

(CHS)

Rating:44Neutral
Price Target:
The overall stock score reflects significant financial challenges, including ongoing losses, high leverage, and negative cash flows. While technical indicators suggest short-term momentum, the valuation remains unattractive due to a negative P/E ratio and lack of dividends. Strategic financial restructuring is critical for long-term viability.

Comprehensive Healthcare Systems Inc (CHS) vs. iShares MSCI Canada ETF (EWC)

Comprehensive Healthcare Systems Inc Business Overview & Revenue Model

Company DescriptionComprehensive Healthcare Systems Inc (CHS) is a company that operates within the healthcare technology sector, focusing on providing innovative solutions and services to improve healthcare delivery and management. The company offers a range of products and services, including healthcare management software, electronic health records (EHR) solutions, and consulting services aimed at optimizing healthcare processes and improving patient outcomes.
How the Company Makes MoneyCHS generates revenue primarily through the sale of its healthcare management software and electronic health records solutions. These products are offered to healthcare providers, hospitals, and clinics on a subscription or licensing basis, providing a steady stream of income. Additionally, the company earns from consulting services, where it assists healthcare organizations in implementing and optimizing their systems. Significant partnerships with healthcare providers and technology firms further enhance their market reach and contribute to revenue growth.

Comprehensive Healthcare Systems Inc Financial Statement Overview

Summary
Comprehensive Healthcare Systems Inc is facing significant financial challenges. Despite some improvement in gross profitability, persistent net losses, a weak balance sheet with high leverage, and negative cash flows highlight financial instability.
Income Statement
35
Negative
The income statement shows a declining trend in revenue with a negative net profit margin of -3.4% in the TTM period. Gross profit margin improved to 43.3% from the previous year, indicating effective cost control. However, consistent net losses and negative EBITDA highlight ongoing operational challenges.
Balance Sheet
20
Very Negative
The balance sheet reveals a negative stockholders' equity, indicating insolvency risks. A high debt-to-equity ratio is concerning, suggesting financial instability. Equity ratio is negative due to liabilities exceeding assets. These factors point to significant financial leverage and risk.
Cash Flow
25
Negative
Cash flow analysis indicates negative free cash flow, hampering operational flexibility. The operating cash flow to net income ratio is positive, showing some cash generation ability, but overall cash flow trends are weak, with reliance on external financing.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Mar 2021
Income StatementTotal Revenue
3.77M3.84M4.30M4.50M6.03M
Gross Profit
2.06M1.15M1.40M1.37M2.63M
EBIT
-979.64K-3.33M-5.14M-1.77M
EBITDA
121.99K-2.86M-4.61M-1.67M
Net Income Common Stockholders
-607.73K-3.58M-5.11M-4.93M
Balance SheetCash, Cash Equivalents and Short-Term Investments
11.03K31.55K400.78K3.40M264.35K
Total Assets
938.55K1.28M2.11M4.11M276.08K
Total Debt
2.50M2.48M1.96M1.76M0.00
Net Debt
2.49M2.46M1.56M-1.64M-264.35K
Total Liabilities
10.19M9.01M5.26M3.50M11.88K
Stockholders Equity
-9.25M-7.73M-3.15M602.59K264.21K
Cash FlowFree Cash Flow
36.31K-1.23M-4.04M-3.28M
Operating Cash Flow
366.80K-1.23M-3.97M-3.27M
Investing Cash Flow
-628.01K0.00-68.41K215.14K
Financing Cash Flow
245.07K852.45K1.04M4.39M3.44M

Comprehensive Healthcare Systems Inc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
C$2.27B-33.64%23.95%39.68%
59
Neutral
C$1.02B30.45-3.53%17.19%-191.01%
56
Neutral
$863.32M-25.08%-0.11%11.22%
54
Neutral
$5.38B3.31-45.11%3.29%16.82%0.04%
TSCHS
44
Neutral
C$2.85M2.18%-7.15%97.22%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CHS
Comprehensive Healthcare Systems Inc
0.23
0.03
15.00%
TSE:CURA
Curaleaf Holdings
1.09
-4.44
-80.29%
TSE:LSPD
Lightspeed POS Inc
14.84
-4.91
-24.86%
TSE:WELL
WELL Health Technologies Corp
3.92
-0.27
-6.44%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.